03/04/2026
Great news!!! 🤞
A medical breakthrough may have just changed everything we know about Parkinson’s disease. Scientists have identified the exact protein interaction that helps the illness spread through the brain and in a stunning twist, they’ve also found a way to block it. The key lies in two proteins, Aplp1 and Lag3, which allow toxic clumps of alpha-synuclein to travel from cell to cell. These clumps are the signature culprits in the neurodegeneration behind Parkinson’s.
The most exciting part? The researchers used an existing FDA-approved cancer drug, nivolumab/relatlimab, to disrupt this process in mice. By targeting Lag3, they reduced the spread of the harmful proteins by up to 90%. This not only opens the door to potentially slowing or halting Parkinson’s but could also lead to new treatments for other diseases like Alzheimer’s. Instead of just managing symptoms, we could soon be stopping neurodegeneration at its source.
With over 8.5 million people living with Parkinson’s globally and no cure in sight until now — this research represents a radical shift in our understanding and treatment approach. And because the drug is already approved for use, clinical trials in humans could come sooner than expected. A new frontier in brain health may have just opened.
https://tinyurl.com/protocol002